Lipid Profile and Cardiovascular Risk Modification after Hepatitis C Virus Eradication

Autor:	Andrea Pascual-Oliver, Diego Casas-Deza, Carmen Yagüe-Caballero, Jose M. Arbones-Mainar, Vanesa Bernal-Monterde
Jazyk:	angličtina
Rok vydání:	2024
Předmět:	hepatitis C virus lipoproteins cardiovascular disease direct-acting antiviral treatment chronic hepatitis C virus treatment insulin resistance Medicine
Zdroj:	Pathogens, Vol 13, Iss 4, p 278 (2024)
Druh dokumentu:	article
ISSN:	13040278 2076-0817
DOI:	10.3390/pathogens13040278
Popis:	The eradication of the hepatitis C virus (HCV) has revolutionized the hepatology paradigm, halting the progression of advanced liver disease in patients with chronic infection and reducing the risk of hepatocarcinoma. In addition, treatment with direct-acting antivirals can reverse the lipid and carbohydrate abnormalities described in HCV patients. Although HCV eradication may reduce the overall risk of vascular events, it is uncertain whether altered lipid profiles increase the risk of cerebrovascular disease in certain patients. We have conducted a review on HCV and lipid and carbohydrate metabolism, as well as new scientific advances, following the advent of direct-acting antivirals.
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/b03727a4fe764d7db7aebad49fb0b927 Zobrazit plný text záznamu View record in DOAJ